{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"AstraZeneca PLC"},"Symbol":{"label":"Symbol","value":"AZN"},"Address":{"label":"Address","value":"1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA, United Kingdom"},"Phone":{"label":"Phone","value":"+44 2037495000"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales."},"CompanyUrl":{"label":"Company Url","value":"https://www.astrazeneca.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Cindy L. Hoots","title":"Chief Digital &amp; Information Officer"},{"name":"Henry D. Cremisi","title":"Medical Director"},{"name":"Menelas NICOLAS Pangalos","title":"EVP-Biopharmaceuticals Research &amp; Development"},{"name":"Pam P. Cheng","title":"Executive VP-Operations &amp; Information Technology"},{"name":"Pascal Soriot","title":"Chief Executive Officer &amp; Executive Director"},{"name":"Regina Fritsche Danielson","title":"SVP, Head-Research &amp; Early Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}